Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: Tech to stop a pandemic, DNA vaccine against Ebola, and a unique way to attack malaria

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

PATH/Amy MacIver
Research Roundup: Drug-resistant malaria, MDGs, World Breastfeeding Week, LHHS appropriations, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Anti-malaria drug resistance: a threat to global health security

In this guest post, S. Patrick Kachur, MD, MPH, FACPM—chief of the Malaria Branch in the Division of Parasitic Diseases and Malaria at the Center for Disease Control and Prevention’s (CDC) Center for Global Health—and Larry Slutsker, MD, MPH—director of the Division of Parasitic Diseases and Malaria at CDC’s Center for Global Health—write about the emerging global security threat of anti-malaria drug resistance and CDC’s efforts to prevent, detect, and respond to this growing threat.

Read More
Senate supports global health R&D in LHHS appropriations bill

Last week, we reported on exciting policy language included in the Senate Department of Defense appropriations legislation, and earlier this summer, the House and Senate State and Foreign Operations bills also included recognition of the role that new technologies could play in advancing global health.

GHTC
Read More
Research Roundup: Appropriations, Ebola, AIDS 2014, open working groups, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Senate shows strong support for global health R&D in defense appropriations bill and report

Earlier this month, we reported that both the House and Senate Appropriations Committees included language supporting global health research and development (R&D) in their reports concerning funding for the Department of State, foreign operations and related programs.

Read More
PATH/Evelyn Hockstein
Research Roundup: Smart power, TB research, female condoms, HIV resource tracking, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Investing in global health innovation=smart power

During the past year, leaders from the US Global Leadership Coalition (USGLC)—an advocacy organization promoting diplomacy and development—have traveled across America seeking out innovators and innovations that best demonstrate how strategic US investments in global development can enhance America’s foreign policy and security interests—an approach USGLC calls “smart power” diplomacy.

Read More
PATH/Will Boase
Research Roundup: EDCTP Forum, Sayana® Press, a new dengue vaccine, the 21st Century Cures Initiative, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
European and African countries meet to advance health technology development for poverty-related diseases

Earlier this week, Anne Hradský—advocacy coordinator for Global Health Research and Development (R&D), Katharina Scheffler—advocacy officer—and others from Deutsche Stiftung Weltbevoelkerung (DSW)—joined other European and African stakeholders for the Seventh European & Developing Countries Clinical Trials Partnerships (EDCTP) Forum in Berlin, Germany.

Read More
PATH/Robin Biellik
Research Roundup: SFOPS, new FDA guidance, top trends in global health, new report on global health R&D, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
House and Senate support global health R&D in appropriations reports

While lawmakers battled it out on the field last week during the annual Congressional Baseball Game (Democrats won for the sixth year in a row!), they found something they could join together on as the House Appropriations Committee easily approved the State and Foreign Operations Subcommittee’s (SFOPS) appropriations bill on Tuesday afternoon.

GHTC
Read More
International Partnership for Microbicides
Research Roundup: Microbicides, hookworm vaccines, #MomAndBaby, pediatric HIV treatments, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
How R&D is saving #momandbaby and helping children reach their #5thbday

Tomorrow US policymakers and global health advocates will come together to talk progress made on preventing maternal and child deaths.

Read More
NIAID
Research Roundup: FY 2015 appropriations, the Human Vaccines Project, Global Development Lab legislation, new HIV treatments, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Aaron Joel Santos
Could mapping the “human immunome” lead to the next generation of vaccines?

The answer is yes according to a group of 35 leading scientists who have come together to explore new strategies to accelerate vaccine development for deadly diseases such as malaria, HIV, tuberculosis (TB), and cancer.

Read More
PATH/Will Boase
Congress acts on FY 2015 funding; shows lukewarm support for global health R&D

As the DC summer kicks into full swing, Congress has had a busy month moving forward fiscal year (FY) 2015 funding legislation for a variety of government programs including global health research and development (R&D).

GHTC
Read More
PATH/Eric Becker
Research Roundup: New drugs against diarrhea, the End Neglected Tropical Diseases Act, genetically-modified mosquitoes, and mines

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Satvir Malhotra
CSIS panel: R&D fundamental to meeting new global TB targets

The development of new diagnostic, treatment, and prevention products is fundamental to accelerating the decline of the global tuberculosis (TB) burden, panelists from the World Health Organization (WHO), the National Institutes of Health (NIH), and the Bill & Melinda Gates Foundation agreed on during a panel discussion hosted by the Center for Strategic and International Studies (CSIS) on Monday.

Read More
Impact of PCAST recommendations on advancing global health R&D

Recently, there has been a surge of interest in evaluating progress made on the 2012 President’s Council of Advisors on Science and Technology’s (PCAST) recommendations that aim to accelerate research and development (R&D) of new therapeutics.

GHTC
Read More
PATH/Eric Becker
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More